Rankings
▼
Calendar
BEAM FY 2021 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
BEAM
Beam Therapeutics Inc.
$3B
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$52M
+215916.7% YoY
Gross Profit
-$180M
-347.8% margin
Operating Income
-$392M
-757.0% margin
Net Income
-$371M
-714.9% margin
EPS (Diluted)
$-5.77
Cash Flow
Operating Cash Flow
-$66M
Free Cash Flow
-$113M
Stock-Based Comp.
$44M
Balance Sheet
Total Assets
$1.5B
Total Liabilities
$648M
Stockholders' Equity
$827M
Cash & Equivalents
$560M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$52M
$24,000
+215916.7%
Gross Profit
-$180M
-$103M
-74.8%
Operating Income
-$392M
-$133M
-195.6%
Net Income
-$371M
-$195M
-90.5%
← Q4 2020
All Quarters
Q1 2021 →